IPHA | Innate Pharma S.A. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)

*Sign In to persist settings

Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31
Revenue	51.90M	49.64M	12.11M	56.83M	68.97M	79.89M	32.63M	56.16M	17.91M	907.00K	12.47M	10.38M	11.74M	4.32M	7.72M	12.92M	14.29M	6.20M	1.30M
Cost of Revenue	56.02M	51.66M	47.00M	3.04M	45.16M	69.56M	67.00M	48.63M	29.91M	12.09M	7.58M	6.86M	1.64M	3.43M	3.35M	2.56M	2.77M	2.20M	944.00K
Gross Profit	-4.12M	-2.02M	-34.89M	53.79M	23.82M	10.34M	-34.37M	7.53M	-12.00M	-11.18M	4.89M	3.51M	10.10M	893.00K	4.37M	10.37M	11.52M	3.99M	356.00K
Operating Expenses	64.57M	66.06M	59.94M	75.38M	50.87M	74.75M	72.61M	48.59M	28.68M	8.76M	7.66M	6.88M	17.67M	14.58M	19.90M	21.37M	20.61M	11.18M	6.77M
Selling, General & Admin	11.75M	22.44M	25.52M	30.39M	49.58M	19.25M	16.18M	9.33M	5.88M	12.82M	10.67M	9.73M	9.79M	7.06M	10.06M	N/A	N/A	1.84M	1.08M
Research & Development	56.02M	51.66M	47.00M	58.61M	1.60M	69.56M	67.00M	48.63M	29.91M	22.67M	15.13M	13.42M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Other Operating Expenses	-3.20M	-8.04M	-12.59M	-13.62M	-309.00K	-14.06M	-10.57M	-9.37M	-7.11M	-19.00K	179.00K	2.00K	7.88M	32.00K	909.00K	21.37M	20.61M	9.34M	5.69M
Operating Income	-12.67M	-11.65M	-47.83M	-13.69M	-27.05M	5.15M	-39.98M	7.57M	-10.77M	-19.97M	-2.79M	-3.39M	-7.57M	-13.69M	-15.54M	-11.01M	-9.09M	-7.24M	-6.42M
Other Expenses / Income	5.10M	-547.00K	2.35M	-15.53M	6.29M	-2.43M	-8.03M	5.37M	4.07M	319.00K	-99.00K	183.00K	590.00K	32.00K	909.00K	1.15M	173.00K	1.20M	286.00K
Before Tax Income	-7.57M	-57.97M	-45.48M	-63.98M	-20.76M	2.72M	-48.02M	12.94M	-6.71M	-19.65M	-2.89M	-3.20M	-6.98M	-13.66M	-14.63M	-9.85M	-8.92M	-6.04M	-6.13M
Income Tax Expenses	N/A	41.13M	13.66M	6.76M	206.00K	-333.00K	368.00K	301.00K	139.00K	-24.00K	-51.00K	-146.00K	1.13M	N/A	46.00K	N/A	51.00K	1.20M	286.00K
Net Income	-7.57M	-99.10M	-59.14M	-70.75M	-20.96M	3.05M	-48.38M	12.64M	-6.71M	-19.65M	-2.89M	-3.20M	-6.98M	-13.66M	-14.63M	-9.85M	-8.92M	-6.04M	-6.13M
Interest Expenses	640.00K	5.32M	4.00M	6.76M	204.00K	102.00K	113.00K	124.00K	139.00K	N/A	N/A	225.00K	520.00K	509.00K	N/A	36.00K	39.00K	2.00K	N/A
Basic Shares Outstanding	80.45M	79.64M	79.54M	78.93M	66.91M	58.78M	54.35M	53.87M	51.58M	50.15M	38.70M	37.80M	37.69M	37.44M	26.30M	25.66M	25.08M	17.77M	14.90M
Diluted Shares Outstanding	80.45M	79.64M	79.54M	78.93M	66.91M	58.78M	54.35M	53.87M	53.40M	50.15M	38.70M	37.80M	37.69M	37.44M	26.30M	25.66M	25.08M	17.77M	14.90M
EBITDA	-1.84M	-61.30M	-43.23M	43.10M	-20.86M	-3.30M	-35.65M	10.83M	-8.09M	-17.14M	-1.91M	-1.76M	-5.80M	-12.32M	-14.47M	-12.48M	-8.50M	-6.94M	-6.11M
EBITDA Margin	-3.54%	-123.48%	-356.91%	75.85%	-30.25%	-4.14%	-109.25%	19.29%	-45.18%	-1,889.53%	-15.32%	-17.00%	-49.41%	-285.23%	-187.48%	-96.54%	-59.51%	-112.04%	-470.31%
EBIT	-6.93M	-52.65M	-41.48M	-57.22M	-20.55M	2.82M	-47.90M	13.06M	-6.43M	-19.67M	-2.94M	-3.12M	-5.33M	-13.15M	-14.58M	-9.82M	-8.83M	-4.84M	-5.84M
EBIT Margin	-13.35%	-106.07%	-342.48%	-100.68%	-29.80%	3.53%	-146.81%	23.26%	-35.90%	-2,168.80%	-23.60%	-30.07%	-45.41%	-304.38%	-188.96%	-75.95%	-61.78%	-78.18%	-449.46%
Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31